Reply to: Letter to the Editor from Malik et al.: Acute kidney injury following subcutaneous meloxicam administration

J Vet Pharmacol Ther. 2024 May;47(3):237-238. doi: 10.1111/jvp.13438. Epub 2024 Mar 10.

Authors

Alex Krekis¹, Jonathan N King², Duncan D'Arcy-Howard³, Nadene Stapleton³, Jonathan Elliott⁴, Ludovic Pelligand^{4

5}

Affiliations

¹ Davies Veterinary Specialists, Hitchin, UK.
² J.N.King Consultancy, Bennwil, Switzerland.
³ Department of Clinical Science and Services, Beaumont Sainsbury Animal Hospital, Royal Veterinary College, University of London, London, UK.
⁴ Department of Comparative Biomedical Sciences, Royal Veterinary College, University of London, London, UK.
⁵ Department of Clinical Science and Services, Queen Mother Hospital for Animals, Royal Veterinary College, University of London, London, UK.

PMID: 38462540
DOI: 10.1111/jvp.13438

No abstract available

Publication types

Letter

MeSH terms

Acute Kidney Injury* / chemically induced
Acute Kidney Injury* / veterinary
Animals
Anti-Inflammatory Agents, Non-Steroidal / administration & dosage
Anti-Inflammatory Agents, Non-Steroidal / adverse effects
Injections, Subcutaneous / adverse effects
Injections, Subcutaneous / veterinary
Meloxicam* / administration & dosage
Meloxicam* / adverse effects
Meloxicam* / therapeutic use
Thiazines* / administration & dosage
Thiazines* / adverse effects
Thiazoles* / administration & dosage
Thiazoles* / adverse effects

Substances

Meloxicam
Thiazoles
Thiazines
Anti-Inflammatory Agents, Non-Steroidal